Sentence examples for men for prostate from inspiring English sources

They urged doctors to stop screening older men for prostate cancer, which will kill an estimated 28,600 men in the United States this year.

The sensitivity and specificity profile of measuring levels of prostate-specific antigen (PSA) to select men for prostate biopsy is not optimal.

Two major studies have found that PSA testing -- the annual blood test used to screen men for prostate cancer -- saves few if any lives, while exposing patients to treatments that can leave them impotent and incontinent.

In an article published in December in The American Journal of Medicine, researchers from the University of North Carolina and the University of Massachusetts in Boston noted that screening men for prostate cancer had become popular even though it had not been shown to be lifesaving in a randomized clinical trial.

Last week, two major studies from the United States and Europe found that P.S.A. testing — the annual blood test used to screen men for prostate cancer — saves few if any lives, while exposing patients to aggressive and unnecessary treatments that can leave them impotent and incontinent.

So the American College of Physicians offers this guidance to doctors: "Rather than screening all men for prostate cancer as a matter of routine, physicians should describe the potential benefits and known harms of screening, diagnosis and treatment, listen to the patient's concerns and then individualize the decision to screen".

Given the ongoing controversy, the responsibility for the decision to screen a man for prostate cancer is a key issue in the PSA debate.

For men screening for prostate cancer, the data are less clear.

Ted Schenberg, the chief executive at Strand, offered to supply the data: more than 13,000 biopsy results from men evaluated for prostate cancer at a number of laboratories.

The study, published online Feb. 22, 2018, by JAMA Oncology included 651 men screened for prostate cancer with blood tests and digital rectal exams.

Excluding men hospitalized for prostate cancer treatment made no difference in the results — it was biopsy alone, not treatment, that led to hospitalization.